Cgt, I remember NIH only funding drugs at Phase II but if Trius have funding in preclinical, not sure why Biota can't.
RSV Phase I early 2013, maybe they will try and secure funding then but I guess all other drugs have been put on the backburner to focus on LANI.
I did ask PC about funding for RSV and other drugs and he said they would consider looking into it.
I feel PC has done a great job with the pipeline of drugs we have, non-dilutive funding, great results with LANI (he sounded quite positive with the Inavir prevention study results which was quite unlike him :) and HRV too so some credit must be given though frustration with the SP is understandable.
- Forums
- ASX - By Stock
- BTA
- melbourne meeting
melbourne meeting, page-10
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
Previous Video
Next Video
SPONSORED BY The Market Online